Welcome to our dedicated page for Ofs Capital SEC filings (Ticker: OFS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading a 300-page OFS Capital Corp filing packed with loan-level fair-value marks and leverage covenants can feel overwhelming. Finding the dividend coverage ratio or tracking when executives buy shares often takes hours.
Our platform solves that problem. AI-powered summaries turn complex sections of the OFS Capital annual report 10-K simplified into plain English, while real-time alerts surface OFS Capital Form 4 insider transactions the moment they hit EDGAR. Want the latest OFS Capital quarterly earnings report 10-Q filing? It鈥檚 here with instant trend analysis. Need to monitor OFS Capital 8-K material events explained after portfolio exits or credit downgrades? We flag them within minutes.
Beyond headline numbers, you鈥檒l discover:
- Net asset value movements and leverage metrics drawn from every 10-Q
- Fee structures and board pay right inside the OFS Capital proxy statement executive compensation
- Segment-level loan concentrations highlighted so you can gauge credit risk quickly
- OFS Capital insider trading Form 4 transactions with historical charts to spot buying patterns
Whether you鈥檙e comparing yield, watching for covenant breaches or simply understanding OFS Capital SEC documents with AI, our coverage spans every filing type鈥�10-K, 10-Q, 8-K, Forms 3 & 4, S-3 and more. Skip the jargon and focus on decisions with OFS Capital SEC filings explained simply and OFS Capital earnings report filing analysis delivered the way professionals read them.
White Hat Capital group filed Amendment No. 4 to its Schedule 13D on Comtech Telecommunications (CMTL) dated 21 Jul 2025. The group 鈥� six affiliated funds plus principals David J. Chanley and Mark R. Quinlan 鈥� now reports beneficial ownership of up to 4.81 million shares, or 9.99 % of the 29.4 million shares outstanding. Holdings include 4.40 million shares issuable on conversion of Series B-3 preferred stock and 54,655 RSUs. A 9.99 % 鈥淏locker鈥� in the preferred certificate prevents further conversions that would push ownership above that threshold.
The disclosure responds to the issuer鈥檚 Amendment No. 2 to its Subordinated Credit Agreement executed 21 Jul 2025, which materially revises the capital structure:
- Introduces a $35 million incremental priority subordinated unsecured term loan (extended by lenders other than White Hat) that ranks senior to existing subordinated loans.
- Interest accrues paid-in-kind monthly at the greater of the senior term-loan rate or Term SOFR + 10.5 %; no make-whole premium.
- Suspends fixed-charge coverage, net-leverage and minimum EBITDA covenant tests until the four-quarter period ending 31 Jan 2027.
- Lowers minimum quarterly average liquidity to $15 million (from $17.5 million).
- Resets stepped minimum EBITDA covenant: $26 m (Q4 FY27) rising to $32 m from Q4 FY27 onward.
- Permits a specified asset disposition and requires management incentive/retention plans.
No share transactions were effected by the reporting persons in the past 60 days.
Fidelity Covington Trust鈥檚 Form N-CSR aggregates FY 2025 results (ended 5/31/25) for six 鈥淒isruptive鈥� ETFs.
- Fidelity Disruptors ETF (fund-of-funds): 1-yr NAV return +14.68% vs. MSCI ACWI +14.02%; since 4/16/20 +13.12% vs. +15.35%. Assets $90.2 m; zero advisory fee; turnover 5%. Portfolio 81.2% domestic equity ETFs, 18.8% international; top sleeves are Disruptive Communications (21.1%) and Finance (21.0%).
- Fidelity Disruptive Technology ETF: +14.72% outpacing sector index (+13.20%); AUM $169.9 m; fee 0.50%; 46 holdings led by MSFT 6.4% & NVDA 6.1%.
- Disruptive Communications ETF: +19.63% roughly inline with sector index (+19.98%); AUM $69.1 m; Sea Ltd 7.2% top weight.
- Disruptive Automation ETF: +11.45% lagging industrials index (+13.96%); AUM $120.5 m; TSMC & PTC each 5.8%.
- Disruptive Finance ETF: +25.56% below financials index (+28.46%); AUM $53.8 m; Mastercard 6.5% largest position.
- Disruptive Medicine ETF: 鈥�0.19% vs. healthcare index +4.44%; AUM $49.6 m; Boston Scientific 6.5%.
Global equity tailwinds and stock selection in application software, interactive entertainment and payment processing aided Technology and Communications, while poor picks in biotechnology, aerospace/defense and payments weighed on Medicine, Automation and Finance. All funds instituted a contractual cap on proxy/shareholder-meeting expenses. Independent audits show combined FY 2025 audit fees: Deloitte $23.8 k (FDIF) and PwC $183 k (other five ETFs).
Heron Therapeutics (HRTX) 鈥� Form 4 filing
On 19 Jul 2025, CEO & Director Craig A. Collard acquired 13,797 common shares through the vesting and settlement of an equal number of restricted stock units (RSUs) granted 19 Jan 2024. The RSUs, which carry a $0 exercise price, vest in 16 equal quarterly tranches; this filing records the fourth installment. Following the transaction Collard鈥檚 direct ownership increased to 439,749 common shares, while 137,969 RSUs remain outstanding. No shares were sold or transferred, and no option exercises or cash proceeds were reported.
The transaction is routine insider equity vesting that modestly lifts insider ownership but does not reflect a discretionary open-market purchase or sale. Market impact is expected to be minimal.
OFS Capital Corporation (Nasdaq: OFS) filed an 8-K disclosing that it will partially redeem its 4.75% Notes due 2026. On 21 Aug 2025, the company will retire $69 million of the $125 million principal outstanding鈥攁bout 55% of the issue. The notes will be repurchased at the greater of (a) 100% of par or (b) a make-whole price equal to the present value of remaining payments discounted at the applicable Treasury rate plus 50 bp; accrued interest will also be paid.
This move removes a meaningful portion of fixed-rate debt carrying a 4.75% coupon, reducing future interest expense and near-term refinancing risk. The filing does not specify the cash source or the exact make-whole premium, but management鈥檚 ability to fund a majority redemption signals liquidity strength and balance-sheet flexibility. No other financial metrics or guidance changes were provided.
On 16 Jul 2025, OFS Capital Corporation (Nasdaq: OFS) executed an Underwriting Agreement with Lucid Capital Markets, Goldman Sachs & Co. LLC and other underwriters covering the public issuance of $69 million aggregate principal amount of 7.50% senior notes due 2028. The total includes a $9 million over-allotment option that was fully subscribed. The notes were sold under the Company鈥檚 effective shelf Registration Statement on Form N-2 (File No. 333-278170) and are expected to be listed on the Nasdaq Global Select Market. No other material events were disclosed in this Form 8-K.
The transaction extends OFS Capital鈥檚 debt maturity profile to 2028 and provides immediate liquidity, but it also introduces a fixed 7.50% interest obligation. Details of covenants, use of proceeds or pricing relative to par were not included in the filing. The full Underwriting Agreement is filed as Exhibit 1.1.
OFS Capital Corporation (Nasdaq: OFS) has launched an underwritten public offering of unsecured notes; pricing, coupon and maturity will be set at closing. The Company has applied to list the notes on the Nasdaq Global Select Market under ticker 鈥淥贵厂厂翱鈥�, with trading targeted to begin within 30 days of issuance.
Use of proceeds: net funds are earmarked to partially redeem the Company鈥檚 outstanding $125 million 4.75% notes due 2026. OFS has already notified holders that it will repurchase $25 million of these 2026 notes on 11 Aug 2025, paying accrued interest plus any make-whole premium.
Lucid Capital Markets, LLC and Goldman Sachs & Co. LLC are joint lead book-running managers. A shelf registration statement is effective, and the offer will be made solely by the prospectus and prospectus supplement filed on 16 Jul 2025.
The transaction, if completed, will extend the Company鈥檚 debt maturity profile and may affect future interest expense; however, specific terms, sizing and timing remain subject to market conditions.
OFS Capital Corporation (NASDAQ: OFS) has filed a Notification of Redemption (Form N-23C-2) with the U.S. Securities and Exchange Commission.
The filing states that the company will redeem a portion of its 4.75% Notes due 2026 (CUSIP 67103B AA8). A total of $25 million in aggregate principal amount will be called on August 11, 2025. The redemption is being carried out under Section 1101 of the base indenture dated April 16, 2018 and Section 1.01(h) of the Fifth Supplemental Indenture dated February 10, 2021.
The notice was signed by Chief Executive Officer Bilal Rashid on July 11, 2025.
OFS Capital Corporation (NASDAQ: OFS) has announced a partial redemption of its 4.75% Notes due 2026. According to the Form 8-K filed on July 11, 2025, the company has issued formal notice to redeem $25 million principal amount out of the $125 million outstanding in this debt tranche. The redemption will be executed on August 11, 2025 under the terms of the 2018 Indenture and the Fifth Supplemental Indenture dated February 10, 2021.
The redemption price will be the greater of (i) 100% of the principal of the Notes called or (ii) the make-whole amount鈥攖he present value of remaining scheduled principal and interest payments discounted at the applicable Treasury rate plus 50 basis points. Holders will also receive accrued and unpaid interest up to the redemption date.
Once completed, the transaction will retire 20% of the series鈥� outstanding balance. While the filing does not disclose funding sources or projected interest savings, the reduction in fixed-rate debt could modestly lower ongoing interest expense and improve leverage ratios, provided the company funds the redemption from available liquidity rather than new borrowing.
The notice of redemption is included as Exhibit 99.1 to the filing. No other material events, financial results, or operational updates were reported.
FAQ
What is the current stock price of Ofs Capital (OFS)?
What is the market cap of Ofs Capital (OFS)?
What type of investment company is OFS Capital Corp?
How does OFS Capital generate income?
What kinds of loans does OFS Capital invest in?
Which market segment does the company target?
How does the company differentiate its investment approach?
What risk management strategies does OFS Capital employ?
How is OFS Capital's business model unique?
How does OFS Capital compare with its competitors?
